258 related articles for article (PubMed ID: 9621021)
1. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
Schang LM; Phillips J; Schaffer PA
J Virol; 1998 Jul; 72(7):5626-37. PubMed ID: 9621021
[TBL] [Abstract][Full Text] [Related]
2. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.
Schang LM; Rosenberg A; Schaffer PA
J Virol; 2000 Mar; 74(5):2107-20. PubMed ID: 10666240
[TBL] [Abstract][Full Text] [Related]
3. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.
Schang LM; Rosenberg A; Schaffer PA
J Virol; 1999 Mar; 73(3):2161-72. PubMed ID: 9971799
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
[TBL] [Abstract][Full Text] [Related]
5. The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0.
Davido DJ; Von Zagorski WF; Maul GG; Schaffer PA
J Virol; 2003 Dec; 77(23):12603-16. PubMed ID: 14610183
[TBL] [Abstract][Full Text] [Related]
6. The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.
Davido DJ; Leib DA; Schaffer PA
J Virol; 2002 Feb; 76(3):1077-88. PubMed ID: 11773384
[TBL] [Abstract][Full Text] [Related]
7. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.
Kudoh A; Daikoku T; Sugaya Y; Isomura H; Fujita M; Kiyono T; Nishiyama Y; Tsurumi T
J Virol; 2004 Jan; 78(1):104-15. PubMed ID: 14671092
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
11. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.
Taylor SL; Kinchington PR; Brooks A; Moffat JF
J Virol; 2004 Mar; 78(6):2853-62. PubMed ID: 14990704
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.
Holcakova J; Muller P; Tomasec P; Hrstka R; Nekulova M; Krystof V; Strnad M; Wilkinson GW; Vojtesek B
PLoS One; 2014; 9(2):e89228. PubMed ID: 24586613
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication.
Schang LM
Biochim Biophys Acta; 2004 Mar; 1697(1-2):197-209. PubMed ID: 15023361
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation.
Roy S; He R; Kapoor A; Forman M; Mazzone JR; Posner GH; Arav-Boger R
Antimicrob Agents Chemother; 2015 Jul; 59(7):3870-9. PubMed ID: 25870074
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.
Zydek M; Hagemeier C; Wiebusch L
PLoS Pathog; 2010 Sep; 6(9):e1001096. PubMed ID: 20844576
[TBL] [Abstract][Full Text] [Related]
16. Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.
Diwan P; Lacasse JJ; Schang LM
J Virol; 2004 Sep; 78(17):9352-65. PubMed ID: 15308730
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity.
Evers DL; Breitenbach JM; Borysko KZ; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2002 Aug; 46(8):2470-6. PubMed ID: 12121920
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.
Sanchez V; McElroy AK; Yen J; Tamrakar S; Clark CL; Schwartz RA; Spector DH
J Virol; 2004 Oct; 78(20):11219-32. PubMed ID: 15452241
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions.
Song B; Yeh KC; Liu J; Knipe DM
Virology; 2001 Nov; 290(2):320-8. PubMed ID: 11883196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
